The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Garassino, Marina Chiara
Item TypeName
Concept Immunotherapy
Academic Article Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
Academic Article DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.
Academic Article The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST.
Academic Article Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis.
Academic Article Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system.
Academic Article Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.
Academic Article Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Academic Article Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity.
Academic Article Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer.
Academic Article Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy.
Academic Article Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis.
Academic Article Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
Academic Article Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
Academic Article Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases.
Academic Article Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.
Academic Article Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study.
Academic Article Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers.
Academic Article Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy.
Academic Article Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Academic Article Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don't) know.
Academic Article Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out.
Academic Article Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
Academic Article Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis.
Academic Article Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting.
Academic Article Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 =50% who progress on first-line immunotherapy: real-world data from a European cohort.
Academic Article Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
Academic Article Is the chemotherapy era in advanced non-small cell lung cancer really over? Maybe not yet.
Academic Article EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort.
Academic Article Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology Assembly.
Academic Article Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Academic Article Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations.
Academic Article Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
Academic Article Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Academic Article Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer.
Academic Article Is hyperprogressive disease a specific phenomenom of immunotherapy?
Academic Article Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.
Search Criteria
  • Immunotherapy